1-33036828-T-C
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001625.4(AK2):c.1A>G(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.00000765 in 1,437,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001625.4 start_lost
Scores
Clinical Significance
Conservation
Publications
- reticular dysgenesisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AK2 | NM_001625.4 | c.1A>G | p.Met1? | start_lost | Exon 1 of 6 | ENST00000672715.1 | NP_001616.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000957 AC: 2AN: 208954 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000765 AC: 11AN: 1437220Hom.: 0 Cov.: 31 AF XY: 0.00000561 AC XY: 4AN XY: 712930 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Reticular dysgenesis Pathogenic:3
The start-loss variant NM_001625.4(AK2):c.1A>G, p.(Met1?) was identified in a homozygous state in a proband diagnosed with reticular dysgenesis in Russian pilot NBS project covering more than 200,000 newborns. This variant has been previously reported in the literature multiple times (PMIDs: 19043417) and is listed in gnomAD v2.1.1 two times in heterozygous individuals. The loss of translation initiation codon should lead to near complete reduction in translation level or synthesis of N-terminally truncated protein (the next ATG-codon located in position Met49. Taken together, the variant meets the following ACMG/AMP criteria and can be classified as pathogenic with PM2, PP3, PVS1, PP5, PP4 criteria. -
- -
The start lost c.1A>G (p.Met1?) variant in AK2 gene has been reported previously in compound heterozygous state in an individual affected with reticular dysgenesis (Pannicke et al., 2009).The p.Met1? variant is predicted to disrupt the initiation codon, and thus potentially may interfere with protein expression -
Severe combined immunodeficiency disease Pathogenic:1
Variant summary: AK2 c.1A>G (p.Met1Val) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. An alternative downstream in-frame start codon (Met49) is located in the encoded protein. An activation of potential downstream translation initiation site would result in a shortened protein missing the first 48 amino acids from the protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 9.6e-06 in 208954 control chromosomes. c.1A>G has been observed as a biallelic genotype in multiple individuals affected with Reticular Dysgenesis (e.g. Pannicke_2009, Guilcher_2017, Marakhonov_2024). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 27913909, 28331055, 38578360, 19043417). ClinVar contains an entry for this variant (Variation ID: 18252). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at